Companies formed
Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.
Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
Navenio


A revolutionary new approach to indoor positioning that combines data from mobile phone sensors with map information such as floor plans, and wifi “maps” where available, to give highly accurate location information without the need for any further hardware.
Incorporated in December 2015
Origin: Oxford University, Department of Computer Science
Bodle Technologies

Orbit Discovery


Peptide display company identifying potential peptide drugs for a range of chronic diseases
Incorporated in November 2015
Origin: Oxford University, Weatherall Institute of Molecular Medicine
Sonosine (Oxford Enhanced Medical Limited)


Their system uses electromagnetic and acoustic waves to create a new class of medical images at a cost comparable to ultrasound.
Incorporated in October 2015
Origin: Oxford University, Department of Engineering Science
Oxford Flow


Oxford Flow’s industrial pressure regulators use innovative technology to provide new levels of performance for natural gas transmission, water distribution and process industries.
Incorporated in September 2015
Origin: Oxford University, Department of Engineering Science
Xerion Healthcare

iOx Therapeutics Limited
Developing a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford’s Weatherall Institute of Molecular Medicine.
Origin: Oxford University, Radcliffe Department of Medicine
Mixergy


Developing domestic energy storage capacity and facilitating its operation within the existing power distribution infrastructure.
Incorporated in April 2015
Origin: Oxford University, Department of Engineering Science
Animal Dynamics


Animal Dynamics marries fine-engineering skills with a deep understanding of the fundamental mechanisms, to produce revolutionary machines that will change the shape of the future, taking inspiration from our environment in order to protect it, and capable of performance beyond anything currently found in nature or engineering.
Incorporated in April 2015
Origin: Oxford University, Department of Zoology
Wrapidity (Diadem)


Domain-centric intelligent automated data extraction methodology.
Incorporated in February 2015
Origin: Oxford University, Department of Computer Science
2014
Oxbotica


Oxbotica. Robotics, autonomous systems, driverless pods.
Incorporated in October 2014
Origin: Oxford University, Department of Engineering Science
Deontics


Deontics is software which guides doctors and patients through the scientific and clinical decision making.
Incorporated in August 2014
Origin: Oxford University, Department of Engineering Science
OxSyBio


Developing 3D printing techniques to produce a range of tissue-like and functional tissues for medical research and clinical applications. Their vision is to ultimately produce tissues that can be used in the clinic for organ repair or replacement.
Origin: Oxford University, Department of Chemistry
Designer Carbon Materials


Designer Carbon Materials, Developing advanced nanomaterials for a range of applications, including energy harvesting, bio-sensing and quantum nanoelectronics.
Incorporated in April 2014
Origin: Oxford University, Department of Materials
Genomics plc


Develop cutting edge software applications that uncover the relationships between genetic variation and human disease.
Help pharmaceutical companies de-risk the drug development process.
Incorporated in March 2014
Origin: Oxford University, Wellcome Trust Centre for Human Genetics
OxCept

OxSonics


OxSonics provide economic and scalable life-changing treatments to solid tumour cancer patients.
Incorporated in January 2014
Origin: Oxford University, Institute of Biomedical Engineering
NightStar Therapeutics (acquired by Biogen)


A private biopharmaceutical company focused on the development of therapies for retinal dystrophies. NightStar Therapeutics was acquired by Biogen in June 2019.
Incorporated in January 2014
Origin: Oxford University, Nuffield Department of Clinical Neurosciences
2013
Oxford Mestar


A rapidly grown, energetic company specialising in translational and regenerative medicine.
Incorporated in December 2013
Origin: Oxford University, Institute of Biomedical Engineering